• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchHerantis Pharma Oyj
    Picture of Herantis Pharma Oyj logo

    HRTIS — Herantis Pharma Oyj Share News

    €1.300.000.00%
    fi flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapSucker Stock
    • Market Cap
      €34.40m
    • Enterprise Value
      €34.34m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • HRTIS Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    HRTIS Dividends
    • Brief: Herantis Pharma H1 net loss increases to EUR 13.6 million

      19/08/2015 08:21
    • Brief: Herantis granted almost EUR 3 million government loan for Parkinson study

      30/06/2015 08:00
    • Brief: Herantis Pharma announces results from phase 2 Cis-UCA Dry Eye study

      03/06/2015 06:01
    • Brief: Finvector Vision Therapies initiates arbitration proceedings against Herantis Pharma unit

      09/03/2015 10:00
    • Brief: Herantis Pharma proposes no 2014 dividend

      27/02/2015 15:31
    • Brief: Herantis Pharma 2014 net loss widens to EUR 8.4 million

      27/02/2015 08:01
    • Brief: Herantis Pharma starts Phase II study with Cis-UCA Eye Drops

      07/01/2015 07:01
    • Brief: Herantis Pharma announces FDA clearance of IND for Phase 2 Cis-UCA Eye Drops study

      08/09/2014 06:51
    Previous12345Next

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.